Prescripción de inhibidores de acetilcolinesterasa y memantina en canarias: comparación con la población española

In the Canary Islands the prescriptions billed to the National Health System are registered in a database (FarmaCanarias). The main objective was to estimate the consumption of Acetylcholinesterase inhibitors (IACE) and Memantine in Canary Islands and to compare with a Spanish sample from Pharmacoep...

Descripción completa

Detalles Bibliográficos
Autores: Rodríguez Espinosa, Norberto, González-Colaço Harmand, Magali, Miranda Saavedra, Francisco, Galván González, Miguel Angel, Plasencia Núñez, Mercedes, Aldea-Perona, Ana, Boada Fernández del Campo, Carlos
Tipo de recurso: artículo
Fecha de publicación:2021
País:España
Institución:Universidad Europea (UEM)
Repositorio:ABACUS. Repositorio de Producción Científica
Idioma:español
OAI Identifier:oai:abacus.universidadeuropea.com:11268/14577
Acceso en línea:http://hdl.handle.net/11268/14577
Access Level:acceso abierto
Palabra clave:Inhibidores de la colinesterasa
Farmacología
España
id ES_c75d8edee5b585079cbdad2b65005d82
oai_identifier_str oai:abacus.universidadeuropea.com:11268/14577
network_acronym_str ES
network_name_str España
repository_id_str
spelling Prescripción de inhibidores de acetilcolinesterasa y memantina en canarias: comparación con la población españolaPrescription of acetylcholinesterase inhibitors and memantine in the Canary Islands, comparison with the Spanish populationRodríguez Espinosa, NorbertoGonzález-Colaço Harmand, MagaliMiranda Saavedra, FranciscoGalván González, Miguel AngelPlasencia Núñez, MercedesAldea-Perona, AnaBoada Fernández del Campo, CarlosInhibidores de la colinesterasaFarmacologíaEspañaIn the Canary Islands the prescriptions billed to the National Health System are registered in a database (FarmaCanarias). The main objective was to estimate the consumption of Acetylcholinesterase inhibitors (IACE) and Memantine in Canary Islands and to compare with a Spanish sample from Pharmacoepidemiological Research Base in Primary Care (PRBPC) which is national in scope. As secondary we determined the percentage in treatment in the Spanish sample. Methods: The prescriptions of IACE and / or memantine in 2017 were calculated as Defined Daily Doses per 100 habitants (DHD) in FarmaCanarias and PRBPC. The prescriptions in FarmaCanarias were disclosed by island and age groups were also compared. The percentage of cases in treatment was calculated in PRBPC from records with diagnosis of "dementia". All the comparations were made by Pearson's χ2. Results: The prescription of IACE and Memantine was: 3.042% (95% CI; 3.039-3.045) and 1.584% (95% CI; 1.582-1.587) in The Canary islands, respectively and 2.545% (95% CI; 2.518-2.572) and 0.922% (95% CI; 0.906-0.938), in PRBPC (p<0.001). DHDs between islands were different, except in two (p<0.001) The distribution by age group between FarmaCanarias and PRBPC was hetereogeneous (p<0.001). The percentage of dementia cases in treatment in PRBPC was 45.51% (95% CI; 45.186-45.838). Conclusions: The prescription of IACE and Memantine was higher in the Canary Islands, which added to the difference by age group, suggests epidemiological differences in dementia compared to the mainland. There is heterogeneity between islands that could be due to epidemiological factors, provider or the Public Health Service.20252025-04-2720212021-01-0120212021-01-01journal articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/11268/14577reponame:ABACUS. Repositorio de Producción Científicainstname:Universidad Europea (UEM)Españolspaopen accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:abacus.universidadeuropea.com:11268/145772026-06-11T12:41:27Z
dc.title.none.fl_str_mv Prescripción de inhibidores de acetilcolinesterasa y memantina en canarias: comparación con la población española
Prescription of acetylcholinesterase inhibitors and memantine in the Canary Islands, comparison with the Spanish population
title Prescripción de inhibidores de acetilcolinesterasa y memantina en canarias: comparación con la población española
spellingShingle Prescripción de inhibidores de acetilcolinesterasa y memantina en canarias: comparación con la población española
Rodríguez Espinosa, Norberto
Inhibidores de la colinesterasa
Farmacología
España
title_short Prescripción de inhibidores de acetilcolinesterasa y memantina en canarias: comparación con la población española
title_full Prescripción de inhibidores de acetilcolinesterasa y memantina en canarias: comparación con la población española
title_fullStr Prescripción de inhibidores de acetilcolinesterasa y memantina en canarias: comparación con la población española
title_full_unstemmed Prescripción de inhibidores de acetilcolinesterasa y memantina en canarias: comparación con la población española
title_sort Prescripción de inhibidores de acetilcolinesterasa y memantina en canarias: comparación con la población española
dc.creator.none.fl_str_mv Rodríguez Espinosa, Norberto
González-Colaço Harmand, Magali
Miranda Saavedra, Francisco
Galván González, Miguel Angel
Plasencia Núñez, Mercedes
Aldea-Perona, Ana
Boada Fernández del Campo, Carlos
author Rodríguez Espinosa, Norberto
author_facet Rodríguez Espinosa, Norberto
González-Colaço Harmand, Magali
Miranda Saavedra, Francisco
Galván González, Miguel Angel
Plasencia Núñez, Mercedes
Aldea-Perona, Ana
Boada Fernández del Campo, Carlos
author_role author
author2 González-Colaço Harmand, Magali
Miranda Saavedra, Francisco
Galván González, Miguel Angel
Plasencia Núñez, Mercedes
Aldea-Perona, Ana
Boada Fernández del Campo, Carlos
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv
dc.subject.none.fl_str_mv Inhibidores de la colinesterasa
Farmacología
España
topic Inhibidores de la colinesterasa
Farmacología
España
description In the Canary Islands the prescriptions billed to the National Health System are registered in a database (FarmaCanarias). The main objective was to estimate the consumption of Acetylcholinesterase inhibitors (IACE) and Memantine in Canary Islands and to compare with a Spanish sample from Pharmacoepidemiological Research Base in Primary Care (PRBPC) which is national in scope. As secondary we determined the percentage in treatment in the Spanish sample. Methods: The prescriptions of IACE and / or memantine in 2017 were calculated as Defined Daily Doses per 100 habitants (DHD) in FarmaCanarias and PRBPC. The prescriptions in FarmaCanarias were disclosed by island and age groups were also compared. The percentage of cases in treatment was calculated in PRBPC from records with diagnosis of "dementia". All the comparations were made by Pearson's χ2. Results: The prescription of IACE and Memantine was: 3.042% (95% CI; 3.039-3.045) and 1.584% (95% CI; 1.582-1.587) in The Canary islands, respectively and 2.545% (95% CI; 2.518-2.572) and 0.922% (95% CI; 0.906-0.938), in PRBPC (p<0.001). DHDs between islands were different, except in two (p<0.001) The distribution by age group between FarmaCanarias and PRBPC was hetereogeneous (p<0.001). The percentage of dementia cases in treatment in PRBPC was 45.51% (95% CI; 45.186-45.838). Conclusions: The prescription of IACE and Memantine was higher in the Canary Islands, which added to the difference by age group, suggests epidemiological differences in dementia compared to the mainland. There is heterogeneity between islands that could be due to epidemiological factors, provider or the Public Health Service.
publishDate 2021
dc.date.none.fl_str_mv 2021
2021-01-01
2021
2021-01-01
2025
2025-04-27
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv http://hdl.handle.net/11268/14577
url http://hdl.handle.net/11268/14577
dc.language.none.fl_str_mv Español
spa
language_invalid_str_mv Español
language spa
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:ABACUS. Repositorio de Producción Científica
instname:Universidad Europea (UEM)
instname_str Universidad Europea (UEM)
reponame_str ABACUS. Repositorio de Producción Científica
collection ABACUS. Repositorio de Producción Científica
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869419150891286528
score 15,812429